BridgeMD
New treatment option for Stroke
Official title Characterization and Clinical Trial of a Variable Friction Shoe
ClinicalTrials.gov ID: NCT06234124
What this study is testing
- What it's testing
- More than one million Americans present with foot drop after stroke. As the aging population grows in the United States and across the world, incidence of stroke will grow as age is a key risk factor, thus there will be a need for low-cost, easy-to-use, and scalable solutions to administer proper therapy to promote recovery.
- Time commitment: about 12 weeks
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- At least 3 months poststroke
- Age 18 or older
- Possess a prescribed AFO or be a potential candidate for use of an AFO
- Can ambulate at least 10m with or without an assistive device such as a cane or walker
- Medically stable as determined by physician medical clearance
You likely can't join if
- History of falling more than once a week prior to the stroke
- Gait speed: self-selected velocity (SSV) greater than 1.2 m/s
- Inability to operate in the devices safely and no caregiver assistance available
- Morbid obesity (body mass index \>40 kg/m2)
- Preexisting conditions such as serious cardiac conditions, myocardial infarction, congestive heart failure, demand pacemaker, seizures, excessive...
- Severe deficits in cognition or communication
See the full eligibility criteria
- At least 3 months poststroke
- Age 18 or older
- Possess a prescribed AFO or be a potential candidate for use of an AFO
- Can ambulate at least 10m with or without an assistive device such as a cane or walker
- Medically stable as determined by physician medical clearance
- No expected change in medications for at least 3 months
- Adequate stability at the ankle during stance
- Ability to hear clicking noise made by the VF shoe
- Physician approval
- Ability to give informed consent
- Able to sit unsupported and be able to follow a three-step command
- No unhealed/unresolved orthopedic injury to either upper or lower extremity and no history of severe back pain
- English speaking
- Willing to follow an exercise program with both devices for at least 30 minutes per day, at least 5 days per week for the full length of the program (6 months)
- History of falling more than once a week prior to the stroke
- Gait speed: self-selected velocity (SSV) greater than 1.2 m/s
- Inability to operate in the devices safely and no caregiver assistance available
- Morbid obesity (body mass index \>40 kg/m2)
- Preexisting conditions such as serious cardiac conditions, myocardial infarction, congestive heart failure, demand pacemaker, seizures, excessive dysesthetic pain, and severe lower extremity pathology that would...
- Severe deficits in cognition or communication
- Pregnant women (status determined by self-reporting).
- Co-morbidity that interferes with the study (e.g. significant arthritis or joint problems, history of back injury, neuromuscular disorders, epilepsy, etc.).
- Severe Osteoporosis (status determined by self-reporting).
- Prisoners
- Not currently receiving botox to the lower extremities.
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.